Biovail Announces Second-Quarter 2009 Earnings Release, Conference-Call Details
TORONTO--(BUSINESS WIRE)--Jul. 28, 2009--
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that it will
host a conference call and Webcast on Thursday, Aug 6, 2009, at 8:30
a.m. EDT, for Company executives to discuss second-quarter 2009
financial and operational results.
Following the discussion, Biovail executives will address inquiries from
investment analysts.
A live Webcast of this call will be available through the Investor
Relations section of Biovail’s Web site at www.biovail.com.
To access the call live, please dial 416-641-6124 (Toronto and
International callers) and 1-866-299-8690 (U.S. and Canada). Listeners
are encouraged to dial in 10 minutes before the call begins to avoid
delays.
A replay of the conference call will be available until 7 p.m. EDT on
Thursday, Aug 13, 2009, by dialing 416-695-5800 (Toronto and
International callers) and 1-800-408-3053 (U.S. and Canada), using
access code, 1864477#.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products. The Company is focused on
the development and commercialization of medicines that address unmet
medical needs in niche specialty central nervous system (CNS) markets.
For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.
Source: Biovail Corporation
Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice-President,
Investor Relations & Corporate Communications
|
